Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 457 of 6351
-
Could a simple test replace surgery for endometriosis diagnosis?
Diagnosis Not yet recruitingEndometriosis is a prevalent gynecological condition affecting approximately 10% of women of reproductive age worldwide. It presents with nonspecific but often severe symptoms, including chronic pelvic pain (in 70% of cases) and infertility (in up to 40% of cases), imposing signi…
Sponsor: Region Stockholm • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
LASIK gets a precision upgrade to sharpen night vision
Disease control Recruiting nowTo provide comprehensive evaluation of WaveLight® Plus technology by assessing impact on both functional low-light vision and patient reported outcomes
Phase 4 • Sponsor: Vance Thompson Vision • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Engineered immune cells target abdominal tumors in colorectal cancer trial
Disease control Recruiting nowTo find the highest dose of NK cells that can be given by vein and intraperitoneally (given directly into the abdominal cavity) in combination with cetuximab to patients with colorectal cancer that has spread to the peritoneum.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New hope for tough esophageal cancer: phase 3 trial launches
Disease control Recruiting nowThis study is designed to assess the efficacy and safety of QLC5508 in patients with unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC) who have experienced disease progression following treatment with a platinum-based systemic therapy and an immune che…
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
A gentle touch may soothe Preemies' pain during blood tests
Symptom relief Recruiting nowPremature infants frequently experience painful procedures during their admission to neonatal intensive care units; this can lead to acute adverse events, imbalances, and long-term neurodevelopmental implications. This randomized controlled trial evaluates the impact of Gentle Hu…
Sponsor: Kubra Nur Kabakcı Sarıdağ • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New drug aims to protect lungs in autoimmune patients
Disease control Not yet recruitingInterstitial lung disease (ILD) is a common pulmonary manifestation in chronic tissue diseases (CTD), significantly affecting patient's prognosis. The main purpose of this study is to evaluate the efficacy of telitacicept compared with placebo in slowing down the decline in lung…
Phase 3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New weekly shot could shed pounds and ease knee pain
Symptom relief Recruiting nowThis study is being done to look at the safety and effect of NNC0487-0111 in people with excess body weight and knee osteoarthritis when compared to placebo. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NN…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New triple combo aims to tackle Hard-to-Treat liver cancer
Disease control Not yet recruitingThis prospective, single-arm, multicenter Phase II clinical trial aims to evaluate the efficacy and safety of Benmelstobart plus anlotinib combined with SBRT in patients with oligometastatic hepatocellular carcinoma who have failed first-line targeted therapy. Key study questions…
Phase 2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control By invitation onlyThis is a multicenter, single-arm, phase II clinical study evaluating the efficacy and safety of neoadjuvant finotonlimab (anti-PD-1), cetuximab (anti-EGFR), and docetaxel in patients with resectable recurrent head and neck squamous cell carcinoma (HNSCC) who have progressed afte…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immunotherapy plus chemotherapy shows promise in rectal cancer trial
Disease control Recruiting nowThis is a multicenter, phase III, randomized controlled trial. Eligible patients with pMMR/MSS locally advanced rectal cancer will be randomized in a 1:1 ratio to either the experimental group or the control group using stratified randomization, with mesorectal fascia (MRF) statu…
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New pill vs. infusion: which works better for severe colitis?
Disease control Recruiting nowThis clinical trial aims to evaluate the comparative efficacy and safety of upadacitinib versus infliximab as second-line treatments for acute severe ulcerative colitis, addressing the following key questions: (1) Can upadacitinib as a second-line therapy effectively induce remis…
Phase 4 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cocktail aims to shrink head and neck tumors before surgery
Disease control Recruiting nowThis is a randomized controlled, phase II clinical study designed to explore the efficacy and safety of nimotuzumab combined with immunotherapy and chemotherapy as neoadjuvant treatment for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). The primary endpoint of…
Phase 2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New combo therapy aims to stall advanced lung cancer
Disease control Not yet recruitingThis study intends to carry out prospective, randomized controlled clinical trials in many centers across the country to compare the efficacy and safety of immunotherapy after standard first-line chemotherapy or immunotherapy combined with interventional bronchial artery chemoemb…
Phase 4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Your own stem cells could rebuild a dying hip bone
Disease control Recruiting nowThe commercial decalcified bone scaffold combined with the patient's autologous bone marrow mesenchymal stem cells was used for in vitro culture to form tissue-engineered bone, and the effect of this tissue-engineered bone in early non-traumatic femoral head necrosis was explored…
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Which pill tames pregnancy diabetes better?
Disease control Recruiting nowThe goal of this randomized clinical trial is to compare metformin and glyburide for controlling blood sugar in pregnant women with gestational diabetes mellitus (GDM) who require treatment with oral medication. The main question the study aims to answer is: Q: Is treatment fai…
Phase 4 • Sponsor: Nishtar Medical University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for stomach cancer patients with abdominal spread
Disease control Recruiting nowIn this study, the investigators will use LM-302 and S-1 plus intraperitoneal paclitaxel with or without Cadonilimab to treat Claudin 18.2-positive gastric or gastroesophageal junction adenocarcinoma with peritoneal metastasis.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug azenosertib takes on Chemo-Resistant ovarian cancer in phase 3 trial
Disease control Recruiting nowThis is a randomized, Phase 3 trial designed to evaluate the efficacy and safety of azenosertib compared to Investigator's choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expression.
Phase 3 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug combo aims to wipe out stomach cancer before surgery
Disease control Recruiting nowThis study is a prospective, randomized, open, multicenter phase II clinical trial. It plans to enroll 70 participants with locally advanced gastric and gastroesophageal junction adenocarcinoma (G/GEJ AC) who are assessed as suitable for D2 radical surgery and capable of R0 resec…
Phase 2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Bionic arm breakthrough? new implant aims for natural control
Disease control Recruiting nowThe CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyography (EMG) sensor array designed to provide control of upper-limb prostheses. The study will assess surgical feasibility, device f…
Sponsor: Phantom Neuro Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a diabetes drug curb heavy drinking in HIV patients?
Disease control Recruiting nowThe goal of this clinical trial is to learn if the drug semaglutide works to reduce alcohol intake among adults living with HIV. The main questions it aims to answer are: 1. Does semaglutide lower the average number of alcoholic beverages participants drink per week? 2. Does sem…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC